FUNDING:
This study was supported by the Eunice Kennedy Shriver National
Institute of Child Health and Human Development (NICHD)-sponsored Pelvic
Floor Disorders Network (PFDN) (U10 HD054214 University of California
San Diego, California; U10 HD041267 Duke University, North Carolina; U10
HD041261 University of Alabama at Birmingham, Alabama; U10 HD069013
Brown Women and Infants Hospital, Rhode Island; U10 HD069025 University
of New Mexico, New Mexico; U10 HD069010 University of Pennsylvania,
Pennsylvania; U10 HD069006 University of Pittsburgh, Pennsylvania; U10
HD054215 Cleveland Clinic, Ohio; U01 HD069031 RTI International, North
Carolina) and the National Institutes of Health Office of Research on
Women’s Health (NIH-ORWH). The NICHD project scientist (DM) for the PFDN
at the time of this study had a role in the development of the protocol
and management of the study; preparation, review, and approval of the
manuscript. The funding of the study was managed by other NIH employees.
Partial support for this study was supplied by Boston Scientific
Corporation through an unrestricted grant to the Pelvic Floor Disorders
Network Data Coordinating Center, RTI International. Boston Scientific
had no role in study design; collection, management, analysis, and
interpretation of data; writing of the manuscript; or the decision to
submit the manuscript for publication.
Research training support for STB was provided by the National
Academies of Sciences, Engineering, and Medicine ’s Ford Foundation
Predoctoral Fellowship Program. The Ford Foundation had a role in
providing research training support. The Ford Foundation had no role in
study design; collection, management, analysis, and interpretation of
data; writing of the manuscript; or the decision to submit the
manuscript for publication.
The content of this article is solely the responsibility of the authors
and does not necessarily represent the official views of the NIH or the
Ford Foundation.